Evidence map›Paper›PMID 37058241›Full record

ArticleInfection2023

SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations.

Rodrigo García-López, Xaira Rivera-Gutiérrez, Mauricio Rosales-Rivera, Selene Zárate, José Esteban Muñoz-Medina, Benjamin Roche, Alfredo Herrera-Estrella, Bruno Gómez-Gil, Alejandro Sanchez-Flores, Blanca Taboada and 1 more

Abstract read
In one paragraph

Article in Infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rodrigo García-López *Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico. rodrigo.garcia@ibt.unam.mx.ORCID https://orcid.org/0000-0002-6713-8085
Xaira Rivera-Gutiérrez *Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.ORCID https://orcid.org/0000-0003-1330-8285
Mauricio Rosales-Rivera *Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.ORCID https://orcid.org/0000-0001-5843-8556
Selene ZáratePosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-1034-204X
José Esteban Muñoz-MedinaCoordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-1289-4457
Benjamin RocheMIVEGEC, Université de Montpellier, IRD, CNRS, Montpellier, France.ORCID https://orcid.org/0000-0001-7975-4232
Alfredo Herrera-EstrellaLaboratorio Nacional de Genómica Para La Biodiversidad-Unidad de Genómica Avanzada, Centro de Investigación y de Estudios Avanzados del IPN, Irapuato, Mexico.ORCID https://orcid.org/0000-0002-4589-6870
Bruno Gómez-GilCentro de Investigación en Alimentación y Desarrollo AC, Unidad Mazatlán, Mazatlán, Mexico.ORCID https://orcid.org/0000-0002-3695-3597
Alejandro Sanchez-FloresUnidad Universitaria de Secuenciación Masiva y Bioinformática, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.ORCID https://orcid.org/0000-0003-0476-3139
Blanca TaboadaDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico. blanca.taboada@ibt.unam.mx.ORCID https://orcid.org/0000-0003-1896-5962
Carlos F AriasDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.ORCID https://orcid.org/0000-0003-3130-4501

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales ANRS0138Agence Nationale de Recherches sur le Sida et les Hépatites Virales ECTZ184596Consejo Nacional de Ciencia y Tecnología 829902Consejo Nacional de Ciencia y Tecnología PP-F003
6 · The paper itself

Abstract

purposeThe swift expansion of the BW.1 SARS-CoV-2 variant coincided with a rapid increase of COVID-19 cases occurring in Southeast Mexico in October, 2022, which marked the start of Mexico's sixth epidemiological wave. In Yucatan, up to 92% (58 of 73) of weekly sequenced genomes between epidemiological week 42 and 47 were identified as either BW.1 or its descendant, BW.1.1 in the region, during the last trimester of 2022. In the current study, a comprehensive genomic comparison was carried out to characterize the evolutionary history of the BW lineage, identifying its origins and its most important mutations.

methodsAn alignment of all the genomes of the BW lineage and its parental BA.5.6.2 variant was carried out to identify their mutations. A phylogenetic and ancestral sequence reconstruction analysis with geographical inference, as well as a longitudinal analysis of point mutations, were performed to trace back their origin and contrast them with key RBD mutations in variant BQ.1, one of the fastest-growing lineages to date.

resultsOur ancestral reconstruction analysis portrayed Mexico as the most probable origin of the BW.1 and BW.1.1 variants. Two synonymous substitutions, T7666C and C14599T, support their Mexican origin, whereas other two mutations are specific to BW.1: S:N460K and ORF1a:V627I. Two additional substitutions and a deletion are found in its descending subvariant, BW.1.1. Mutations found in the receptor binding domain, S:K444T, S:L452R, S:N460K, and S:F486V in BW.1 have been reported to be relevant for immune escape and are also key mutations in the BQ.1 lineage.

conclusionsBW.1 appears to have arisen in the Yucatan Peninsula in Southeast Mexico sometime around July 2022 during the fifth COVID-19 wave. Its rapid growth may be in part explained by the relevant escape mutations also found in BQ.1.

Indexed as

COVID-19SARS-CoV-2HumansMexicoMutationPhylogenyCOVID-19Genomic surveillanceMutationsOmicronSARS-CoV-2 variants

Identifiers

PMID37058241
PMCPMC10103656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.